Art

J-GLOBAL ID：200902157794245892   Reference number：02A0339910

Effects of a Single Oral Dose of Cilostazol on Epicardial Coronary Arteries and Hemodynamics in Humans.

ヒトにおけるシロスタゾール単回経口投与の血液動力学と心外膜冠状動脈への効果

Author (9)： YASUTAKE M (Nippon Medical School, Tokyo, JPN) ,  KUNIMI T (Nippon Medical School, Tokyo, JPN) ,  SATO N (Nippon Medical School, Tokyo, JPN) ,  YOKOYAMA H (Nippon Medical School, Tokyo, JPN) ,  SASAKI Y (Nippon Medical School, Tokyo, JPN) ,  KUSAMA Y (Nippon Medical School, Tokyo, JPN) ,  HATA N (Nippon Medical School, Tokyo, JPN) ,  MUNAKATA K (Nippon Medical School, Tokyo, JPN) ,  KISHIDA H (Nippon Medical School, Tokyo, JPN)
Material： Circulation Journal  (Circ J)
Volume： 66  Issue： 3  Page： 241-246  Publication year： Mar. 2002 
JST Material Number： F0908A  ISSN： 1346-9843  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： cyclic-AMP phosphodiesterase ,...
Semi thesaurus term： coronary artery ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=02A0339910&from=J-GLOBAL&jstjournalNo=F0908A") }}

JST classification (1)： Clinical application of drugs acting on blood and body fluid  (GW14020X)

Substance index (2)： Cilostazol ,  Nitroglycerin

Reference (38)：

• 1. Hennekens CH, Buring JE, Sandercock P, Collins R, Peto R. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation 1989; 80: 749-756.
• 2. Thompson PL, Aylward PE, Federman J, Giles RW, Harris PJ, Hodge RL, et al. A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction: National Heart Foundation of Australia Coronary Thrombolysis Group. Circulation 1991; 83: 1534-1542.
• 3. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii: 349-360.
• 4. Haynes RB, Sandler RS, Larson EB, Pater JL, Yatsu FM. A critical appraisal of ticlopidine, a new antiplatelet agent: Effectiveness and clinical indications for prophylaxis of atherosclerotic events. Arch Intern Med 1992; 152: 1376-1380.
• 5. Lefkovits J, Topol EJ. Role of platelet inhibitor agents in coronary artery disease. In: Topol EJ, editor. Textbook of interventional cardiology, 3rd edn. Philadelphia: WB Saunders Co; 1999: 3-24.

Terms in the title (6)： ヒト ,  シロスタゾール ,  経口投与 ,  血液動力学 ,  心外膜 ,  冠状動脈